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Study Objectives
Clinical guidelines from professional societies including 
ACEP and the European Society of Cardiology suggest that 
outpatient management is safe for low-risk patients with 
venous thromboembolism (VTE). With FDA clearance of 
direct oral anticoagulants (DOACs), there has been a shift in 
treating low-risk VTE patients with DOACs in the outpatient 
setting compared to admission. This study sought to 
describe differences in the management of VTE related to 
sex of the patient in context of the Covid Pandemic.
Methods
We performed a retrospective analysis on a quality 
improvement database of a convenience sample of patients 
diagnosed with VTE during the Covid pandemic between 
9/1/2020 and 2/28/2021. Patients were included if they 
were evaluated in the ED at one of a network of six 
hospitals in NE Pennsylvania: three northern rural 
community hospitals, one Level 1 trauma/academic center, 
one suburban hospital and one center city hospital. 
Results
454 patients, 219 female (48.2%) and 235 
(51.8%) male, were diagnosed with VTE 
between 9/1/20 and 2/28/21. Of these, 248 
(54.6%) were admitted for VTE treatment 
and 206 (45.4%) were discharged. Data 
include 235 males and 219 females, with  
an average age of 58 and 61 years, 
respectively. The range in length of stay 
(LOS) for the female group was 37–2,776 
minutes with an average of 389 minutes  
vs. a range of 70–1,545 minutes with an 
average of 396 minutes for the male group. 
Regarding disposition, 127 (57.9%) females 
were admitted and 92 (42.0%) were 
discharged vs. 121 (51.5%) males admitted 
and 114 (48.5%) discharged (p=0.164). 
Twenty-seven (12.3%) of the female patients 
and 33 (14.0%) of the males did not have a  
follow-up appointment scheduled at 
discharge (p=0.590). There were 27 patients 
that returned within 30 days with a VTE 
diagnosis, 13 were females and 14 were 
males (p=0.992). Of those who returned 
that had been discharged, 9 were females 
(69.3%) compared to 4 (28.6%) males. Of 
those who returned that had been 
admitted, 4 were females (30.7%) vs. 10 
(71.4%) males. DOACs were prescribed to 
127 (57.9%) female patients and the 
anticoagulant breakdown was as follows:  
82 (64.6%) receiving apixaban, 33 (25.9%) 
rivaroxaban, 7(5.5%) enoxaparin and 5 
(3.9%) warfarin compared to 126 (53.6%) 
male patients: 65 (51.6%) receiving 
apixaban, 37 (29.4%) rivaroxaban, 18 (14.3%) 
enoxaparin and 6 (4.8%) warfarin.
Conclusion
During the COVID pandemic at a six-hospital network in 
Northeast PA there was no sex specific difference in 
disposition of patients presenting to the ED with VTE.  
There were some sex specific differences in medication 
management and return visits, but the numbers in our 
study were too small to generate confident clinical and 
statistical significance.  Further study with a larger dataset to 
determine the impact of these potential sex specific 
differences on patient outcomes as well as to elucidate the 
impact COVID has on the decision-making process for 
management is indicated.
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